49,006
edits
Difference between revisions of "P16"
Jump to navigation
Jump to search
no edit summary
| Line 42: | Line 42: | ||
Image:Consistent with HPV-associated SCC - p16 -- high mag.jpg | c/w HPV-assoc. SCC - p16 - high mag. (WC/Nephron) | Image:Consistent with HPV-associated SCC - p16 -- high mag.jpg | c/w HPV-assoc. SCC - p16 - high mag. (WC/Nephron) | ||
</gallery> | </gallery> | ||
===Penile cancer=== | ===Penile cancer=== | ||
*p16 is considered surrogate for HPV and ''block-type positivity'' is considered indicative of HPV.<ref name=pmid36221864>{{cite journal |authors=Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Compérat E, Hartmann A, Netto G, Rubin MA, Gill AJ, Turajlic S, Tan PH, Raspollini MR, Tickoo SK, Amin MB |title=WHO 2022 classification of penile and scrotal cancers: updates and evolution |journal=Histopathology |volume=82 |issue=4 |pages=508–520 |date=March 2023 |pmid=36221864 |doi=10.1111/his.14824 |url=}}</ref> | *p16 is considered surrogate for HPV and ''block-type positivity'' is considered indicative of HPV.<ref name=pmid36221864>{{cite journal |authors=Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Compérat E, Hartmann A, Netto G, Rubin MA, Gill AJ, Turajlic S, Tan PH, Raspollini MR, Tickoo SK, Amin MB |title=WHO 2022 classification of penile and scrotal cancers: updates and evolution |journal=Histopathology |volume=82 |issue=4 |pages=508–520 |date=March 2023 |pmid=36221864 |doi=10.1111/his.14824 |url=}}</ref> | ||
* | **A meta-analysis from 2018 shows that various p16 staining criteria have been used in the past.<ref name=pmid29987099>{{cite journal |authors=Sand FL, Rasmussen CL, Frederiksen MH, Andersen KK, Kjaer SK |title=Prognostic Significance of HPV and p16 Status in Men Diagnosed with Penile Cancer: A Systematic Review and Meta-analysis |journal=Cancer Epidemiol Biomarkers Prev |volume=27 |issue=10 |pages=1123–1132 |date=October 2018 |pmid=29987099 |doi=10.1158/1055-9965.EPI-18-0322 |url=}}</ref> | ||
<pre> | <pre> | ||